Gene polymorphisms of inflammatory factors in liver cirrhosis

Introduction: Studies on the association between gene polymorphisms of various inflammatory factors and liver cirrhosis have been inconsistent. The purpose of this study was to comprehensively summarize the available evidence on the association between gene polymorphisms of inflammatory factors and liver cirrhosis through a systematic review. Methods: We searched databases of PubMed, EMBASE, Web of Science, and the Cochrane Library for relevant articles published from building databases to 25 September 2022. A systematic review and meta‐analysis were performed to investigate the association between gene polymorphisms of various inflammatory factors and liver cirrhosis. Odds ratios (OR) and 95% confidence intervals (CI) were used to assess the strength of association. Results: A total of 43 articles were included in the systematic review and of them, 22 articles were included in the meta‐analysis. The gene polymorphisms of IL-10–1082 GA + AA vs. GG (OR = 1.43, 95% CI = 1.12–1.83), IL-10–1082 AA vs. GG (OR = 2.03, 95% CI = 1.36–3.02), IL-18 -137 GG vs. CC (OR = 3.84, 95% CI = 1.29–11.40), TGF-β1 -509 T vs. C (OR = 2.52, 95% CI = 1.42–4.48), and IFN-γ +874 T vs. A (OR = 1.98, 95% CI = 1.32–2.98) were associated with liver cirrhosis significantly and no association was observed in other gene polymorphisms included in the meta‐analysis. The review of inflammatory factors gene polymorphisms that were only reported by a single study indicated 19 gene polymorphisms were risk factors and 4 gene polymorphisms were protective factors for liver cirrhosis, while the association between other 27 gene polymorphisms and liver cirrhosis were not statistically significant. Discussion: This study suggests that IL-10 -1082G/A, IL-18 -137G/C, TGF-β1 -509T/C, and IFN-γ +874T/A were potentially associated with the risk of liver cirrhosis susceptibility. These findings may provide comprehensive evidence for genetic susceptibility and immunogenetic pathology of liver cirrhosis.

[1]  Chang Liu,et al.  A Meta-Analysis of the Influence of Tumor Necrosis Factor-α-308 Gene Polymorphism on Liver Cirrhosis , 2022, Journal of healthcare engineering.

[2]  Hua Zeng,et al.  IL-6 and IL-10 gene polymorphisms and cirrhosis of liver risk from a comprehensive analysis , 2021, BMC Endocrine Disorders.

[3]  G. Temel,et al.  Possible relationship between IL28B rs12979860 and TLR2 -196 to -174 del/ins polymorphisms and the liver fibrosis stage in hepatitis C patients , 2021, Archives of virology.

[4]  H. Nomeir,et al.  TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis , 2021, Asian Pacific journal of cancer prevention : APJCP.

[5]  Pere Ginès,et al.  Liver cirrhosis , 2021, The Lancet.

[6]  J. Fallowfield,et al.  Emerging synthetic drugs for the treatment of liver cirrhosis , 2021, Expert opinion on emerging drugs.

[7]  Chuanmin Tao,et al.  Relationships between IL-1β, TNF-α genetic polymorphisms and HBV infection: A meta-analytical study. , 2021, Gene.

[8]  P. Muriel,et al.  Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver , 2020, Antioxidants.

[9]  M. Sadeghi,et al.  Association between interleukin 6 polymorphisms (rs1800796, rs1800795, rs2069837, rs17147230, and rs1800797) and hepatocellular carcinoma susceptibility: a meta-analysis , 2020, Clinical and experimental hepatology.

[10]  A. Périanin,et al.  The innate immune cells in cirrhosis. , 2020, Journal of hepatology.

[11]  T. H. Nguyen,et al.  The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The lancet. Gastroenterology & hepatology.

[12]  M. Pinzani,et al.  Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. , 2019, Molecular aspects of medicine.

[13]  P. Kamath,et al.  Burden of liver diseases in the world. , 2019, Journal of hepatology.

[14]  Chaolong Zhang,et al.  Transforming growth factor-β1 gene polymorphisms with liver cirrhosis risk: A meta-analysis. , 2018, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[15]  Z. Dai,et al.  IL-18 polymorphisms contribute to hepatitis B virus-related cirrhosis and hepatocellular carcinoma susceptibility in Chinese population: a case-control study , 2017, Oncotarget.

[16]  Z. Dai,et al.  IL-18 polymorphisms contribute to hepatitis B virus-related cirrhosis and hepatocellular carcinoma susceptibility in Chinese population: a case-control study , 2017, Oncotarget.

[17]  C. Pairojkul,et al.  Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke Opisthorchis viverrini-Associated Advanced Periductal Fibrosis and Cholangiocarcinoma , 2017, The Korean journal of parasitology.

[18]  S. Friedman,et al.  Mechanisms of hepatic stellate cell activation , 2017, Nature Reviews Gastroenterology &Hepatology.

[19]  A. Feldstein,et al.  Inflammasomes in Liver Fibrosis , 2017, Seminars in Liver Disease.

[20]  Y. Koyama,et al.  Liver inflammation and fibrosis. , 2017, The Journal of clinical investigation.

[21]  A. Medvedev,et al.  Molecular mechanisms of regulation of Toll‐like receptor signaling , 2016, Journal of leukocyte biology.

[22]  S. Dooley,et al.  TGF‐β signalling and liver disease , 2016, The FEBS journal.

[23]  W. Liu,et al.  IL10 rs1800896 polymorphism is associated with liver cirrhosis and chronic hepatitis B. , 2016, Genetics and molecular research : GMR.

[24]  Shan Li,et al.  Role of IL-18 Gene Promoter Polymorphisms, Serum IL-18 Levels, and Risk of Hepatitis B Virus-related Liver Disease in the Guangxi Zhuang Population: a Retrospective Case-Control Study. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[25]  Hongjie Song,et al.  Association between interleukin-10 gene promoter polymorphisms and susceptibility to liver cirrhosis. , 2015, International journal of clinical and experimental pathology.

[26]  Shan Li,et al.  Interferon gamma polymorphisms and hepatitis B virus-related liver cirrhosis risk in a Chinese population , 2015, Cancer Cell International.

[27]  Pengfei Guo,et al.  Influence of IL10 gene polymorphisms on the severity of liver fibrosis and susceptibility to liver cirrhosis in HBV/HCV-infected patients. , 2015, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[28]  A. Zhang,et al.  Interleukin-10 gene promoter polymorphism and risk of liver cirrhosis. , 2015, Genetics and molecular research : GMR.

[29]  A. Fouad,et al.  Role of transforming growth factor-β1 in serum and − 509 C>T promoter gene polymorphism in development of liver cirrhosis in Egyptian patients , 2014, Meta gene.

[30]  Sun-Chong Wang,et al.  Interleukin 10 promoter haplotype is associated with alcoholic liver cirrhosis in Taiwanese patients , 2014, The Kaohsiung journal of medical sciences.

[31]  M. Radwan,et al.  Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients. , 2012, Cytokine.

[32]  Michael Karin,et al.  A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. , 2012, Gastroenterology.

[33]  Y. Liu,et al.  Lack of an association between -308G>A polymorphism of the TNF-α gene and liver cirrhosis risk based on a meta-analysis. , 2011, Genetics and molecular research : GMR.

[34]  M. Pirisi,et al.  IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC. , 2011, Journal of hepatology.

[35]  W. Jeong,et al.  Suppression of innate immunity (natural killer cell/interferon‐γ) in the advanced stages of liver fibrosis in mice , 2011, Hepatology.

[36]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[37]  L. Chouchane,et al.  Combined analysis of interferon-gamma and interleukin-10 gene polymorphisms and chronic hepatitis C severity. , 2009, Human immunology.

[38]  C. Avellini,et al.  TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer. , 2008, Cytokine.

[39]  J. Armendáriz-Borunda,et al.  Fibrogenic Polymorphisms (TGF-β, PAI-1, AT) in Mexican Patients With Established Liver Fibrosis. Potential Correlation With Pirfenidone Treatment , 2008, Journal of Investigative Medicine.

[40]  L. Chouchane,et al.  Association of interleukin‐18 polymorphisms and plasma level with the outcome of chronic HCV infection , 2008, Journal of medical virology.

[41]  M. Raptopoulou-Gigi,et al.  Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1–TH2 cytokine profile in subjects with self‐limited disease , 2007, Journal of viral hepatitis.

[42]  R. González-Sarmiento,et al.  -238 G>A polymorphism of tumor necrosis factor alpha gene (TNFA) is associated with alcoholic liver cirrhosis in alcoholic Spanish men. , 2005, Alcoholism, clinical and experimental research.

[43]  M. Manns,et al.  Cytokine gene polymorphisms and the susceptibility to liver cirrhosis in patients with chronic hepatitis C , 2003 .

[44]  G. Davis,et al.  Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. , 2000, Gastroenterology.

[45]  S. Akira,et al.  IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. , 1998, Journal of immunology.

[46]  Abeer Sheneef,et al.  Interleukin-10 and Interferon Gamma Gene Polymorphisms and Hepatitis C Virus-Related Liver Cirrhosis Risk. , 2017, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[47]  N. Méndez-Sánchez,et al.  Management strategies for liver fibrosis. , 2017, Annals of hepatology.

[48]  H. Shousha,et al.  Interferon-γ and Interleukin-10 Gene Polymorphisms are not Predictors of Chronic Hepatitis C (Genotype-4) Disease Progression. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[49]  T. Meitinger,et al.  Do common genetic variants in endotoxin signaling pathway contribute to predisposition to alcoholic liver cirrhosis? , 2009, Clinical chemistry and laboratory medicine.